HER2-Positive Breast Cancer Shows Strong Immune Response to Single Dose of Trastuzumab
News
Case Western University researchers found that a single dose of the anticancer drug trastuzumab induced a strong immune response in HER2-positive breast cancer tumors. Such results confirm previous research suggesting that intrinsic ... Read more